FDA Investigator Keith C Rindahl
Keith C Rindahl has conducted inspections on 37 sites in 1 countries as of 21 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
37
Last Inspection Date:
21 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Keith C Rindahl:
Aaron L Dunbar,
Alecia L Marson,
Amir Alavi,
Ana E Morales,
Boun M Xiong,
Carolyn A Warren,
Catherine M Vanderhoef,
Charles R Cote, RIC,
Christina A Castineyra,
Courtney R Ingalsbe,
Courtney R Tiegs,
Dale A Nyberg,
Demetria L Lueneburg,
Denise L Burosh,
Diane T Reindl,
Elias H Wachter,
Eric A Breselow,
Eric T Huebler,
Jamie R Thompson,
Janis R Armedoriz,
Jasjeet K Sekhon,
Jean M Bosenbecker,
Jeffery A Hangartner,
Jeffry A Bernhardt,
Jennifer Guttuso,
Jesse P Romenesko,
Jessica L Barr,
Joel D Hustedt,
Karla J Youngberg,
Kathryn M Mogen,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kia L Copeland,
Kimberly Lewandowski Walker,
Kimberly W Destromp,
Lee Terry Moore,
Leon R Stratman,
Linda V Weyer,
Lisa M Lopez,
Melissa I Michurski,
Melissa J Holz,
Michelle J Glembin,
Nicole C Shokatz,
Patrick J Campbell,
Rafael A Kaup,
Rebecca L Mullikin,
Richard Jay Tucker, RS,
Richard W Koller,
Sandra D Wilson,
Sandra Sejdinovic,
Sarah A Palmer,
Scott L Schenian,
Shalonda C Clifford,
Susan M North,
Suzanne M Crotty,
Tara M Humfeld,
Wendy L Trefethren Grang,
William P Fournier
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more